Form 8-K - Current report:
SEC Accession No. 0001493152-24-039574
Filing Date
2024-10-04
Accepted
2024-10-04 17:25:46
Documents
15
Period of Report
2024-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47682
2 ex2-1.htm EX-2.1 30019
  Complete submission text file 0001493152-24-039574.txt   317014

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pwup-20241002.xsd EX-101.SCH 4290
4 XBRL DEFINITION FILE pwup-20241002_def.xml EX-101.DEF 30878
5 XBRL LABEL FILE pwup-20241002_lab.xml EX-101.LAB 38244
6 XBRL PRESENTATION FILE pwup-20241002_pre.xml EX-101.PRE 27897
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7595
Mailing Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038
Business Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038 561-704-8527
PowerUp Acquisition Corp. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41293 | Film No.: 241355727
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)